Neuronetics Company Profile

07:57 EST 10th December 2018 | BioPortfolio

Neuronetics is focused on successfully developing and commercializing noninvasive therapies to treat significant, chronic psychiatric and neurological disorders. We are committed to working collaboratively with the clinical community to improve care, at reasonable cost, for the many patients suffering from these disorders.


One Great Valley Parkway, Suite 2
United States of America


Phone: 610-640-4202
Fax: 610-640-4206

News Articles [23 Associated News Articles listed on BioPortfolio]

Neuronetics files for IPO

Neuronetics Inc. (neurostimulation device to treat psychiatric and neurological disorders)

Neuronetics prices $75M IPO

An initial public offering of 5 million shares has been priced by Malvern, Pa.-based Neuronetics at $14 to $16 each in hopes  -More- 

Neuronetics looks to raise $86M in IPO

An initial public offering was filed with the SEC by Malvern, Pa.-based Neuronetics in hopes of raising up to $86 million.  -More- 

Neuronetics announces pricing of $94M IPO

An initial public offering of 5.5 million shares has been priced by Neuronetics at $17 each in hopes of raising $94 million.  -More- 

Neuronetics nets $100mm in IPO

Neuronetics Inc. (neurostimulation device to treat psychiatric and neurological disorders) netted $100mm in its initial public offering of 6.325mm shares (including the overallotment) at $17.00. The c...

Neuronetics Readies $75 Million IPO

Neuronetics: Potential Has Been Recognised By Investors

GE's Bet On Neuronetics: Sell It At 8.32x Forward Sales

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

TMS for Suicidal Crisis in Active Duty SMs

The purpose of this study is to determine if the use of Transcranial Magnetic Stimulation (TMS) provides rapid reduction and sustained attenuation of suicidal crisis. TMS is a treatment fo...

An Evaluation of Safety and Feasibility Using rTMS in Adolescents With Depression

The objective of this investigation is to examine the safety and feasibility of a series rTMS treatments (10 Hz; Left Dorsolateral Prefrontal Cortex), with a Neuronetics Model 2100 CRS Rep...

TMS for Adults With Autism and Depression

The goal of this proposal is to investigate whether a standard rTMS protocol for depression, including multiple sessions applied to left dorsolateral prefrontal cortex (DLPFC) results in r...

Companies [0 Results]


More Information about "Neuronetics" on BioPortfolio

We have published hundreds of Neuronetics news stories on BioPortfolio along with dozens of Neuronetics Clinical Trials and PubMed Articles about Neuronetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neuronetics Companies in our database. You can also find out about relevant Neuronetics Drugs and Medications on this site too.

Quick Search


Relevant Topic

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Corporate Database Quicklinks

Searches Linking to this Company Record